Further evidence supporting the genetic component of AD etiology comes from investigations, which correlated genomic variations in close proximity to the IDE gene with disease severity, plaque and NFT density (72), and the plasma levels of Aβ42 in patients with AD (73). This evidence concerns the gene IDE and Alzheimer disease.